
Spencer has received support from Abbott Labs (grant/research support), Shire (grant/research support, consulting fees, speaker's bureau), Bristol-Myers Squibb (grant/research support) Cephalon (grant/research support), Eli Lilly (grant/research support, consulting fees, speaker's bureau), GlaxoSmithKline (grant/research support, consulting fees, speaker's bureau), McNeil (grant/research support, consulting fees, speaker's bureau), Janssen (grant/research support, consulting fees, speaker's bureau), Celltech (grant/research support, speaker's bureau) Wyeth-Ayerst (grant/research support, speaker's bureau), Novartis (grant/research support, consulting fees, speaker's bureau), and Pfizer (grant/research support, consulting fees). McCracken has received support from Pfizer (grant/research support, consulting fees), Janssen (grant/research support, consulting fees), Solvay (grant/research support), Eli Lilly (grant/research support, speaker's bureau), Shire (grant/research support, consulting fees, speaker's bureau), Bristol-Myers Squibb (grant/research support), BMS (consulting fees), Noven (consulting fees). Lopez has received support from Eli Lilly (grant/research support), Novartis (grant/research support, consulting fees, speaker's bureau), Shire (grant/research support, consulting fees, speaker's bureau), and Novartis (grant/research support, consulting fees, speaker's bureau), Celltech (consulting fees), and Cephalon (grant/research support). Wigal has received support from Eli Lilly (grant/research support), Novartis (grant/research support, speaker's bureau), Shire (grant/research support, consulting fees, speaker's bureau), Celgene (grant/research support, speaker's bureau) Celltech (grant/research support, consulting fees, speaker's bureau), McNeil (grant/research support, consulting fees, speaker's bureau), Cephalon (grant/research support), and Janssen (grant/research support). Biederman has received support from Shire (grant/research support, consulting fees, speaker's bureau), Eli Lilly (grant/research support, consulting fees, speaker's bureau), Pfizer (grant/research support, consulting fees), Cephalon (grant/research support, consulting fees, speaker's bureau), McNeil (consulting fees, speaker's bureau), Janssen (grant/research support, consulting fees), Neurosearch Pharmaceuticals (grant/research support), Stanley Medical Institute (grant/research support), Prechter Foundation (grant/research support), Novartis (consulting fees, speaker's bureau), Johnson & Johnson (consulting fees), New River Pharmaceuticals (grant/research support, consulting fees), and the Lilly Foundation (grant/research support).

McGough has received support from Eli Lilly (grant/research support, speaker's bureau), Novartis (grant/research support, consulting fees, speaker's bureau), Shire (grant/research support, consulting fees, speaker's bureau), Pfizer (grant/research support, consulting fees), and New River Pharmaceuticals (grant/research report). D., for assistance with manuscript preparation.ĭisclosure: Dr. The authors acknowledge the contributions of the SLI381.302 Study Group and thank Tracey I.

This research was supported by Shire Pharmaceutical Development Inc., Wayne, PA.
